Format
Sort by

Send to

Choose Destination

Search results

Items: 4

1.

Use of phage display for the generation of human antibodies that neutralize factor IXa function.

Suggett S, Kirchhofer D, Hass P, Lipari T, Moran P, Nagel M, Judice K, Schroeder K, Tom J, Lowman H, Adams C, Eaton D, Devaux B.

Blood Coagul Fibrinolysis. 2000 Jan;11(1):27-42.

PMID:
10691097
2.

A human antibody that binds to the gamma-carboxyglutamic acid domain of factor IX is a potent antithrombotic in vivo.

Refino CJ, Himber J, Burcklen L, Moran P, Peek M, Suggett S, Devaux B, Kirchhofer D.

Thromb Haemost. 1999 Sep;82(3):1188-95.

PMID:
10494786
3.

Cell activation and apoptosis by bacterial lipoproteins through toll-like receptor-2.

Aliprantis AO, Yang RB, Mark MR, Suggett S, Devaux B, Radolf JD, Klimpel GR, Godowski P, Zychlinsky A.

Science. 1999 Jul 30;285(5428):736-9.

4.

Engineering poliovirus as a vaccine vector for the expression of diverse antigens.

Andino R, Silvera D, Suggett SD, Achacoso PL, Miller CJ, Baltimore D, Feinberg MB.

Science. 1994 Sep 2;265(5177):1448-51.

PMID:
8073288

Supplemental Content

Loading ...
Support Center